The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products.
Ciurea
S
S
Beri
R
R
Dobogai
L
L
Chunduri
S
S
Mahmud
N
N
Rondelli
D
D
Peace
D
D
D000328:Adult; D001793:Blood Preservation / Q000379:methods; D001804:Blood Transfusion, Autologous / Q000523:psychology; D004921:Erythropoietin / Q000494:pharmacology*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D033221:Jehovah's Witnesses / Q000523:psychology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D011994:Recombinant Proteins; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
D011994:Recombinant Proteins; D004921:Erythropoietin